Home
>
US Stocks
>
Fulcrum Therapeutics Inc
Fulcrum Therapeutics Inc
FULC

Fulcrum Therapeutics Inc (FULC)

$12.540.79%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$12.94
Today Low/High$12.42 / $13.56
52 Week Low/High$6.85 / $33.1
Market Cap$564.44M

Company Details

Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet medical need. Fulcrum's proprietary product engine identifies drug targets which can modulate gene expression to treat the known root cause of gene mis-expression. The company has advanced losmapimod to Phase 2 clinical development for the treatment of facioscapulohumeral muscular dystrophy (FSHD). Fulcrum has also advanced FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and beta thalassemia into Phase 1 clinical development.
OrganisationFulcrum Therapeutics Inc
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is Fulcrum Therapeutics Inc (FULC) share price today?

Can Indians buy Fulcrum Therapeutics Inc (FULC) shares?

How can I buy Fulcrum Therapeutics Inc (FULC) shares from India?

Can Fractional shares of Fulcrum Therapeutics Inc (FULC) be purchased?

What are the documents required to start investing in Fulcrum Therapeutics Inc (FULC) stocks?